Cognitive Behavioural Therapy for insomnia (CBTi) as a treatment for tinnitus-related insomnia: Protocol for a randomised controlled trial

Elizabeth Marks, Christopher Hallsworth, Laurence McKenna

Research output: Contribution to journalArticle

Abstract

Background: A significant proportion of patients with chronic tinnitus reportclinical levels of sleep disturbance (insomnia). Despite the significant healthand functioning implications of this, no rigorous trials have investigated treatmentsthat target tinnitus-related insomnia. This is the first randomised controlledtrial evaluating Cognitive Behavioural Therapy for insomnia (CBTi) in tinnitus,compared to other psychological treatments. Methods: The study will test the efficacy of group CBTi as a treatmentfor tinnitus-related insomnia in a single-centre, randomised controlled trial. Participantswill be 102 patients with chronic, clinically significant tinnitus andinsomnia, in the absence of organic sleep disorders. Participants will be randomisedto one of three intervention arms: six sessions of CBTi or six sessions of Sleep Support Group or two sessions of Audiologically Based Care. The primary outcomeswill be changes in sleep as measured on the Insomnia Severity Index and keyoutcomes on a 2-week sleep diary (Sleep Efficiency and Total Sleep Time).Outcomes will be collected 3, 10, 14 and 34 weeks post-randomization. Secondarymeasures include sleep quality, sleep beliefs, tinnitus severity, psychologicaldistress and quality of life. Data on satisfaction and treatment experience willbe collected at 10 and 34 weeks post-randomization. A sub-sample ofparticipants will provide two weeks of actigraphy data at the same time points.Discussion: Findings from the studywill be submitted to a peer-reviewed journal. It is anticipated that findingsmay inform future clinical practice around treatment of tinnitus-relatedinsomnia. Trial Registration: Thetrial was with clinicaltrials.gov on 29 December 2017, RetrospectivelyRegistered (NCT03386123); URL(https://clinicaltrials.gov/ct2/show/NCT03386123?term=insomnia&cond=Tinnitus&rank=1).
Original languageEnglish
JournalTrials
DOIs
Publication statusPublished - 2 Dec 2019

Cite this

Cognitive Behavioural Therapy for insomnia (CBTi) as a treatment for tinnitus-related insomnia: Protocol for a randomised controlled trial. / Marks, Elizabeth; Hallsworth, Christopher; McKenna, Laurence.

In: Trials, 02.12.2019.

Research output: Contribution to journalArticle

@article{833640918072436681c3d711f5969e58,
title = "Cognitive Behavioural Therapy for insomnia (CBTi) as a treatment for tinnitus-related insomnia: Protocol for a randomised controlled trial",
abstract = "Background: A significant proportion of patients with chronic tinnitus reportclinical levels of sleep disturbance (insomnia). Despite the significant healthand functioning implications of this, no rigorous trials have investigated treatmentsthat target tinnitus-related insomnia. This is the first randomised controlledtrial evaluating Cognitive Behavioural Therapy for insomnia (CBTi) in tinnitus,compared to other psychological treatments. Methods: The study will test the efficacy of group CBTi as a treatmentfor tinnitus-related insomnia in a single-centre, randomised controlled trial. Participantswill be 102 patients with chronic, clinically significant tinnitus andinsomnia, in the absence of organic sleep disorders. Participants will be randomisedto one of three intervention arms: six sessions of CBTi or six sessions of Sleep Support Group or two sessions of Audiologically Based Care. The primary outcomeswill be changes in sleep as measured on the Insomnia Severity Index and keyoutcomes on a 2-week sleep diary (Sleep Efficiency and Total Sleep Time).Outcomes will be collected 3, 10, 14 and 34 weeks post-randomization. Secondarymeasures include sleep quality, sleep beliefs, tinnitus severity, psychologicaldistress and quality of life. Data on satisfaction and treatment experience willbe collected at 10 and 34 weeks post-randomization. A sub-sample ofparticipants will provide two weeks of actigraphy data at the same time points.Discussion: Findings from the studywill be submitted to a peer-reviewed journal. It is anticipated that findingsmay inform future clinical practice around treatment of tinnitus-relatedinsomnia. Trial Registration: Thetrial was with clinicaltrials.gov on 29 December 2017, RetrospectivelyRegistered (NCT03386123); URL(https://clinicaltrials.gov/ct2/show/NCT03386123?term=insomnia&cond=Tinnitus&rank=1).",
author = "Elizabeth Marks and Christopher Hallsworth and Laurence McKenna",
year = "2019",
month = "12",
day = "2",
doi = "10.1186/s13063-019-3778-5",
language = "English",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Cognitive Behavioural Therapy for insomnia (CBTi) as a treatment for tinnitus-related insomnia: Protocol for a randomised controlled trial

AU - Marks, Elizabeth

AU - Hallsworth, Christopher

AU - McKenna, Laurence

PY - 2019/12/2

Y1 - 2019/12/2

N2 - Background: A significant proportion of patients with chronic tinnitus reportclinical levels of sleep disturbance (insomnia). Despite the significant healthand functioning implications of this, no rigorous trials have investigated treatmentsthat target tinnitus-related insomnia. This is the first randomised controlledtrial evaluating Cognitive Behavioural Therapy for insomnia (CBTi) in tinnitus,compared to other psychological treatments. Methods: The study will test the efficacy of group CBTi as a treatmentfor tinnitus-related insomnia in a single-centre, randomised controlled trial. Participantswill be 102 patients with chronic, clinically significant tinnitus andinsomnia, in the absence of organic sleep disorders. Participants will be randomisedto one of three intervention arms: six sessions of CBTi or six sessions of Sleep Support Group or two sessions of Audiologically Based Care. The primary outcomeswill be changes in sleep as measured on the Insomnia Severity Index and keyoutcomes on a 2-week sleep diary (Sleep Efficiency and Total Sleep Time).Outcomes will be collected 3, 10, 14 and 34 weeks post-randomization. Secondarymeasures include sleep quality, sleep beliefs, tinnitus severity, psychologicaldistress and quality of life. Data on satisfaction and treatment experience willbe collected at 10 and 34 weeks post-randomization. A sub-sample ofparticipants will provide two weeks of actigraphy data at the same time points.Discussion: Findings from the studywill be submitted to a peer-reviewed journal. It is anticipated that findingsmay inform future clinical practice around treatment of tinnitus-relatedinsomnia. Trial Registration: Thetrial was with clinicaltrials.gov on 29 December 2017, RetrospectivelyRegistered (NCT03386123); URL(https://clinicaltrials.gov/ct2/show/NCT03386123?term=insomnia&cond=Tinnitus&rank=1).

AB - Background: A significant proportion of patients with chronic tinnitus reportclinical levels of sleep disturbance (insomnia). Despite the significant healthand functioning implications of this, no rigorous trials have investigated treatmentsthat target tinnitus-related insomnia. This is the first randomised controlledtrial evaluating Cognitive Behavioural Therapy for insomnia (CBTi) in tinnitus,compared to other psychological treatments. Methods: The study will test the efficacy of group CBTi as a treatmentfor tinnitus-related insomnia in a single-centre, randomised controlled trial. Participantswill be 102 patients with chronic, clinically significant tinnitus andinsomnia, in the absence of organic sleep disorders. Participants will be randomisedto one of three intervention arms: six sessions of CBTi or six sessions of Sleep Support Group or two sessions of Audiologically Based Care. The primary outcomeswill be changes in sleep as measured on the Insomnia Severity Index and keyoutcomes on a 2-week sleep diary (Sleep Efficiency and Total Sleep Time).Outcomes will be collected 3, 10, 14 and 34 weeks post-randomization. Secondarymeasures include sleep quality, sleep beliefs, tinnitus severity, psychologicaldistress and quality of life. Data on satisfaction and treatment experience willbe collected at 10 and 34 weeks post-randomization. A sub-sample ofparticipants will provide two weeks of actigraphy data at the same time points.Discussion: Findings from the studywill be submitted to a peer-reviewed journal. It is anticipated that findingsmay inform future clinical practice around treatment of tinnitus-relatedinsomnia. Trial Registration: Thetrial was with clinicaltrials.gov on 29 December 2017, RetrospectivelyRegistered (NCT03386123); URL(https://clinicaltrials.gov/ct2/show/NCT03386123?term=insomnia&cond=Tinnitus&rank=1).

U2 - 10.1186/s13063-019-3778-5

DO - 10.1186/s13063-019-3778-5

M3 - Article

JO - Trials

JF - Trials

SN - 1745-6215

ER -